Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Lang

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Investigation|October 1, 2020
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer developmentEgle Katkeviciute, Larissa Hering, Ana Montalban-Arques, et al.
The Journal of Clinical Investigation|April 5, 2016
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22Marianne R Spalinger, Stephanie Kasper, Claudia Gottier, et al.
Gut|October 3, 2022
TiO<sub>2</sub> nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locusMarlene Schwarzfischer, Anna Niechcial, Kristina Handler, et al.
Gut Microbes|July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel diseaseYasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Investigation|October 1, 2020
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer developmentEgle Katkeviciute, Larissa Hering, Ana Montalban-Arques, et al.
The Journal of Clinical Investigation|April 5, 2016
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22Marianne R Spalinger, Stephanie Kasper, Claudia Gottier, et al.
Gut|October 3, 2022
TiO<sub>2</sub> nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locusMarlene Schwarzfischer, Anna Niechcial, Kristina Handler, et al.
Gut Microbes|July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel diseaseYasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Pageof 8